Miracle Weight Loss Potion or Menace? The Unsettling Rise of Semaglutide and Tirzepatide as a Weight Loss Phenomenon

For all of us who have certain stubborn fat areas that we'd love to banish, the idea of a miracle weight loss potion sounds like an absolute dream come true. In recent years, three drugs have been making waves in the market as a potential solution for rapid and effective weight loss - Ozempic, Wegovy, and Mounjaro.

Because some of these medications were initially used as diabetes treatments while the other is a newly FDA-approved treatment for obesity, the effects of these drugs on weight loss are still being studied.

While many celebrities and various online medication platforms swear by the effectiveness of these weight loss drugs, there's still much controversy surrounding their long-term safety and potential side effects. With that in mind, let's take a closer look at these seemingly miraculous medications and separate fact from misformation.

Background on Semaglutide and Tirzepatide

Semaglutide, sold as Ozempic and Wegovy, was initially approved for managing Type 2 diabetes. It's part of the GLP-1 agonists class, which simulates an incretin hormone to regulate blood sugar by increasing insulin and decreasing glucagon release, thus lowering blood glucose.

Its weight loss benefits emerged during diabetes trials. Scientists discovered that patients felt less hungry and more full. Semaglutide slows food leaving the stomach, helping control appetite and manage calories, showing potential for obesity treatment.

Tirzepatide: The New Contender

Unlike semaglutide, which subtly interacts with GLP-1 receptors, Mounjaro is the life of the party, engaging with both GLP-1 and GIP receptors.

Why is this significant?

GIP kickstarts insulin release and makes you feel full. So, by hitting both of these areas, Mounjaro takes a fuller approach that could really boost weight loss efforts, not just help manage Type 2 diabetes. As a result, clinical trials claim that Mounjaro can help patients lose more weight than semaglutide class drugs.

What Are the Differences and Similarities Among Ozempic, Wegovy, and Mounjaro

Here's a deeper look into how these medications differ in composition, mechanism of action, and clinical use:

Drug Purpose Approved by FDA

Ozempic and Mounjaro are listed as a diabetes treatment, whereas Wegovy is listed as an obesity treatment. All 3 drugs require a medical prescription.

Administration Form

While Wegovy and Mounjaro only exist in injection form, Ozempic can be administered both through injection and oral pill forms. The pill form is sold under the name Rybelsus.

Dosage and Frequency

Both Ozempic and Wegovy require at least 0.25mg per week, while Mounjaro has a higher recommended dosage of at least 2.5mg per week.

Weight Loss Results

Clinical trials have shown that obese patients, when treated with Ozempic in combination with lifestyle modifications, successfully shed 15% of their body weight over a period of 68 weeks.

Wegovy also produced similar results of allowing obese individuals to maintain a 15% mean weight loss within 2 years of treatment.

Meanwhile, Mounjaro trials showed an even more promising result with a mean weight loss of 26.6% after only 84 weeks.

Benefits of Semaglutide and Tirzepatide for Weight Loss

Not everyone is lucky enough to have a cheetah's metabolism, and our bodies are all different - from how we're built to the hormones that play a role in weight gain. Plus, some folks have extra physical challenges that make shedding pounds even tougher.

For those dealing with conditions like insulin resistance and hormonal imbalance, gaining weight starts this vicious downward spiral that makes it almost impossible to lose weight

And it doesn't stop there.

The insulin problem, increased blood sugar levels, and extra stored fat in the body can lead to other health problems like heart disease, brain issues, troubles with your liver and kidneys, and mental health problems.

As we know, 41.9% of Americans are suffering from obesity. While the American government and health care system have led numerous campaigns to promote healthy lifestyle and diet choices, these haven't been enough to combat the obesity epidemic.

These weight loss treatments serve as a crucial bridge, aiding individuals with pre-existing medical conditions and genetic predispositions in managing their weight and improving their health.

Medications like semaglutide and tirzepatide can really make a difference. They help your body handle insulin better, keep your appetite in check, and manage how much you eat. And when you pair these treatments with proper diet and exercise, it can really boost your journey towards maintaining a healthy weight.

However, it's important to point out that these drugs aren't a shortcut or a magic solution. They should be used in conjunction with healthy lifestyle changes and not as a sole weight loss method.

Side Effects and Safety Concerns

Like all medications, semaglutide and tirzepatide come with potential side effects that can vary in severity and impact on patients. Understanding these side effects is crucial for both healthcare providers and patients to manage expectations and ensure safe usage of these drugs.

Common Side Effects

Gastrointestinal Symptoms

Both semaglutide and tirzepatide commonly cause gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, stomach cramps, bloats, gastric reflux, and gas. These symptoms are often the most severe when starting the medication and may decrease in intensity as the body adjusts over time. However, the severity of these symptoms may also vary from person to person and can persist even after weeks or months of use.

Appetite Changes and Digestive Discomfort

Patients may experience significant changes in appetite, reduced hunger, and delayed gastric emptying, which can lead to discomfort and altered eating patterns. These effects contribute to the weight loss seen with these medications but can also lead to nutritional imbalances if not managed properly.

Hypoglycemia

Especially in patients with Type 2 diabetes, both drugs can cause hypoglycemia (low blood sugar levels) when combined with other diabetes medications. It's essential for patients to monitor their blood sugar levels closely and adjust their medication doses as recommended by a healthcare provider.

Moderate to Severe Side Effects

Pancreatitis

Both medications have been associated with an increased risk of pancreatitis. Patients are advised to watch for symptoms such as severe abdominal pain, nausea, and vomiting, and seek immediate medical attention if they suspect pancreatitis.

Kidney Function

There's concern about the impact of these drugs on kidney function, particularly in patients who already have kidney disease.

Thyroid Tumors

As mentioned, there's a warning for an increased risk of thyroid C-cell tumors based on animal studies for drugs that work like semaglutide and tirzepatide. Patients should be aware of this risk and report any symptoms such as neck masses, difficulty swallowing, or persistent hoarseness.

Gallbladder Issues

There have been reports of gallbladder-related issues, including gallstones and inflammation, particularly when rapid weight loss occurs. Monitoring for symptoms related to gallbladder problems is advised.

Allergic Reactions and Injection Site Reactions

Allergic Reactions

While rare, severe allergic reactions can occur. Symptoms such as rash, itching, swelling of the face, lips, tongue, or throat, difficulty breathing, or feeling faint are serious and require immediate medical attention.

Injection Site Reactions

Patients may experience reactions at the injection site, including redness, swelling, and pain. These reactions are usually mild and resolve on their own but can be bothersome.

Interaction with Other Medications

When managing interactions with other medications, it's crucial to handle semaglutide and tirzepatide with care. 

Problems with Insurance Companies

Depending whether you are using semaglutide or tirzepatide, the cost may vary. However, both medications can be expensive and may not be covered by insurance companies. This can make it challenging for individuals to afford these treatments and continue using them long-term.

At the same time, if you're not using the treatment as approved by the FDA, you may not be able to get coverage for the side effects caused by these reported risks. You may need to cover the cost out of pocket or find alternative treatments that are covered by your insurance provider.

Symptoms of Quick Weight Loss

As more celebrities hop on the weight loss bandwagon with semaglutide and tirzepatide, many people witness the so-called "Ozempic face" or "Ozempic butt" in which their face or certain body parts appear to sag horrible due to rapid fat loss.

At the same time, it's essential to understand the difference between a healthy rate of weight loss and potentially harmful side effects. 

If you do decide to try semaglutide, tirzepatide or any other weight loss medication, but want to avoid these problems, make sure you work closely with a healthcare provider to monitor your progress and address any concerns.

Instead of aiming to lose as much weight as quickly as possible, you may want to go with a lower dosage along with an exercise and diet plan that focuses on long-term, sustainable weight loss.

Side Effects Related to Going Off These Medications

Another problem that many clinical trials don't mention is the number of health problems that come along with rapid weight loss.

Typically, when a person goes off the medication, they gain some or all of their weight back. However, the effect is less if you maintain the new healthy habits you develop while taking the medication.

Physical Withdrawal Symptoms

While you don't mentally crave these medications, your body becomes adjusted to the new levels of blood sugar control and hormonal changes that semaglutide and tirzepatide provide. When you stop taking them, it's like putting your system into a state of shock.

Immediate Rebound Effects

Increased Appetite and Weight Regain

One of the most immediate effects of discontinuing semaglutide is an increase in appetite. Since Semaglutide suppresses appetite as part of its action mechanism, its discontinuation can lead to a sudden increase in hunger levels, often more intense than before starting the medication. This heightened appetite can quickly lead to weight regain unless carefully managed through dietary adjustments and continued lifestyle interventions.

Worsening of Blood Glucose Control

For patients using semaglutide primarily for managing Type 2 diabetes, stopping the medication can lead to a significant increase in blood glucose levels. Semaglutide helps regulate blood sugar by enhancing insulin secretion and reducing glucagon release. Without these effects, patients might see a spike in their glucose levels, which would require a reevaluation of their diabetes management plan and possible adjustments to other medications.

Metabolic and Cardiovascular Adjustments

Changes in Metabolic Rate

The metabolic rate may adjust back up after stopping semaglutide. While on the medication, the body's metabolism adapts to a lower caloric intake and improved insulin sensitivity. Once the medication is discontinued, these adaptations may reverse, potentially leading to a metabolic slowdown, which makes it more challenging to maintain weight loss and manage blood sugar effectively.

Increase in Cardiovascular Risk Factors

Stopping semaglutide might lead to an increase in cardiovascular risk factors, such as elevated blood pressure and lipid levels, especially if significant weight gain follows the discontinuation. Patients who have experienced improvements in cardiovascular health while on the medication should be monitored closely after stopping it to manage any emerging risks effectively.

Psychological and Behavioral Impacts

Psychological Challenges

The psychological impact of regaining appetite and potential weight can be substantial. Patients might experience a sense of loss of control or become discouraged, affecting their overall motivation and commitment to maintaining a healthy lifestyle. Providing psychological support and counseling during this transition period can be beneficial.

Adjustment to New Body Weight and Health Status

Patients need to manage expectations about maintaining weight loss or diabetes control after stopping semaglutide. It's crucial for healthcare providers to communicate clearly about the potential for rebound effects and the necessity for ongoing lifestyle management to prevent disappointment and promote long-term health.

Strategies for a Smooth Transition

If you do decide you want to stop taking semaglutide or tirzepatide, make sure to do so under the guidance of a healthcare provider and monitor for any withdrawal symptoms. It's essential not to abruptly stop these medications without proper medical supervision.

Alternative and Complementary Therapies

While these medications can help reduce insulin resistance and manage blood sugar levels, they don't address the unhealthy relationship between an individual and their eating habits. To achieve long-term success in managing weight, there are other ways to achieve a healthy lifestyle and improve overall health.

Some alternative and complementary therapies to consider include:

• Mindful eating techniques: These can help individuals become more aware of their body's cues for hunger and fullness, leading to healthier food choices.
• Cognitive behavioral therapy (CBT): This type of therapy can help individuals identify and change negative thought patterns and behaviors related to food and eating. For individuals who suffer from food addiction or emotional eating, CBT can be particularly helpful.
• Regular exercise: Engaging in physical activity can't only help with weight management but also improve overall health and well-being. If you find exercising boring, you may want to consider getting a VR headset and playing games that require physical movement, such as dancing or boxing.
• Continuous Glucose Monitoring (CGM): The new generation of CGM devices can provide valuable feedback on blood sugar levels throughout the day, helping you make more informed decisions about your diet and activity levels. Instant feedback is a more effective way to motivate individuals to make healthier choices.
• Herbal supplements: Certain herbs and plant-based supplements, such as cinnamon, ginseng, and fenugreek, have shown potential in managing blood sugar levels. However, it's essential to consult with a healthcare provider before taking any supplements to avoid any potential interactions with other medications or health conditions.
• Support groups: Joining a support group or seeking peer support can be an effective way to stay motivated and learn from others' experiences in managing diabetes and weight loss.

Bottom Line

As we face obesity as a disease, we can combat it with a multifaceted approach that includes medical interventions, lifestyle modifications, and mental health support.

Semaglutide and tirzepatide are promising medications that can help with weight management and blood sugar control in individuals with obesity, diabetes, or hypertension. However, for people who just want a quick fix, these medications may come with too many side effects, leading to a vicious cycle of medication use and discontinuation.

At the same time, we should take a closer look at the root causes of obesity -- foods with hidden amounts of chemicals, preservatives, and hormones that interfere with our body's natural regulatory mechanisms and disrupt our hormones, mood, and appetite.

By addressing these underlying issues, we can improve overall health and potentially reduce the need for medications in the first place.

References

Mounjaro® (tirzepatide) injection and ZepboundTM️ (tirzepatide) injection | Lilly Medicines. (n.d.). https://tirzepatide.lilly.com/

https://www.ozempic.com/

https://www.wegovy.com/

Els, L. C. (2024, February 5). GLP-1 diabetes and weight-loss drug side effects: “Ozempic face” and more. Harvard Health. https://www.health.harvard.edu/staying-healthy/glp-1-diabetes-and-weight-loss-drug-side-effects-ozempic-face-and-more

https://nypost.com/2024/05/10/lifestyle/ozempic-butt-latest-side-effect-of-popular-weight-loss-drug/

https://www.cdc.gov/obesity/data/adult.html

Semaglutide (Subcutaneous route) side effects - Mayo Clinic. (n.d.). https://www.mayoclinic.org/drugs-supplements/semaglutide-subcutaneous-route/side-effects/drg-20406730?p=1

Tirzepatide (Subcutaneous route) side effects - Mayo Clinic. (n.d.). https://www.mayoclinic.org/drugs-supplements/tirzepatide-subcutaneous-route/side-effects/drg-20534045?p=1

Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Drugwatch. (2024, April 3). Mounjaro vs. Ozempic: Effectiveness, Side Effects & Cost Comparison. Drugwatch.com. https://www.drugwatch.com/drugs/ozempic/mounjaro/

Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., Kushner, R. F., & STEP 1 Study Group (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, obesity & metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725

Aronne, L. J., Sattar, N., Horn, D. B., Bays, H., Wharton, S., Lin, W., Ahmad, N., Zhang, S., Liao, R., Bunck, M. C., Jouravskaya, I., Murphy, M. A., Fretes, J. O., Coronel, M. J., Gutnisky, L. L., Frechtel, G., Gelersztein, E., Aizenberg, D., Maldonado, N., . . . Nardandrea, J. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity. JAMA, 331(1), 38. https://doi.org/10.1001/jama.2023.24945